Acadia Pharma Stock Price (NASDAQ:ACAD)

Add to My Stocks
$30.09 $1.09 (3.76%) ACAD stock closing price Jul 20, 2017 (Closing)
Prev Close* : $29.00
Market Cap:
Day Low: $28.99
52 Week Low: $20.68
Open: $29.03
Volume: 1588394
Day High: $30.46
52 Week High: $40.83

Latest Stock Market News

Latest Articles

Acadia Pharma News - From Partners

ACAD Stockcharts

View ACAD PE ratio, PS ratio stocks charts and compare with peers.
ACAD Chart
Note: Compare Acadia Pharma stock price history with the index and industry peers.

Acadia Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Acadia Pharma Financial Ratios

Asset Turnover
Receivables Turnover

ACAD Industry Peers

Company Price Change (%)
Integra Lifesciences (IART)55.70.06 (0.11%)
Galapagos (GLPG)80.854.69 (6.16%)
Eli Lilly (LLY)84.750.52 (0.62%)
Pfizer (PFE)33.540.08 (0.24%)
Adamas Pharma (ADMS)17.620.23 (1.32%)
Axsome Therapeutics (AXSM)5.450 (0%)
Praxsyn (PXYN)0.010 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)40.936.85 (20.1%)
Vericel Corp (VCEL)3.350.2 (6.35%)
Novavax (NVAX)1.510.09 (6.34%)
Uniquire (QURE)8.280.48 (6.15%)
Vital Therapies (VTL)2.80.15 (5.66%)
BioDelivery Sciences (BDSI)3.150.15 (5%)
Idera Pharma (IDRA)1.90.08 (4.4%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 20, 2017
CompanyPriceChange (%)
Inovio Pharma (INO)6.010.77 (11.36%)
AVEO Pharmaceuticals (AVEO)2.520.11 (4.18%)
Epizyme (EPZM)13.30.4 (2.92%)
Immunomedics (IMMU)8.620.25 (2.82%)
Paratek Pharma (PRTK)220.55 (2.44%)
Geron (GERN)2.810.07 (2.43%)
Organovo (ONVO)2.320.05 (2.11%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 20, 2017

ACADIA Pharmaceuticals Inc. Stock News - Partner Headlines

Acadia Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues17.33M0.06M0.12M1.14M4.9M
Net Income-271.39M-164.44M-92.47M-37.94M-20.84M
Total Operating Expense287.06M164.66M93.34M39.44M25.78M
view ACADIA Pharmaceuticals Inc. income statement
balance sheet20162015201420132012
Total Assets561.15M221.89M325.45M189.11M108.59M
Total Liabilities42.74M22.13M15.96M6.98M23.6M
Shareholders Equity518.41M199.76M309.48M182.13M84.98M
view ACADIA Pharmaceuticals Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities4.39M4.11M9.31M-1.12M-2.43M
Net Cash From (Used By) Operating Activities-210.4M-121.79M-66.43M-31.76M-21.63M
Increase (Decrease) In Prop Plant And Equipment-1.5M-2.14M-0.18M-0.6M0.25M
view ACADIA Pharmaceuticals Inc. cashflow statement

Acadia Pharma Stock Message Board

Acadia Pharma stock lost 0.14 %, and the last close price as of 19 Jul, 2017 is 29 for ACAD stock. Acadia Pharma market capitalization is 3.53B and it represents the total market value of ACAD stock. Acadia Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy ACAD stock than sell it, then Acadia Pharma stock price goes up. Conversely, if more investors wanted to sell ACAD stock than buy it, there would be greater supply than demand, and the stock price would fall. 1497444 shares were traded with a closing stock price of 29 as of 19 Jul, 2017, as can be seen from Acadia Pharma stock quote. One can view Acadia Pharma stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Acadia Pharma stock price history, gives the entire historical data for ACAD stock.